Intelligence Β· Clinical Pipeline

Gilead Sciences Ireland Pipeline

All ClinicalTrials.gov programs at Gilead Sciences Ireland β€” phase, modality, and trial IDs.

Programs
26

Quick answer

Gilead Sciences Ireland has 26 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. AZLI 75 mg two times a day (BID)/ three times a day (TID)

    Gilead Sciences Ireland UC

    Cystic Fibrosis

    phase 3 small molecule completed

    1 trial
  2. B/F/TAF

    Gilead Sciences Ireland UC

    HIV-1/HBV Co-Infection

    phase 3 small molecule completed

    1 trial
  3. B/F/TAF (Adult Strength)

    Gilead Sciences Ireland UC

    HIV-1 Infection

    phase 3 small molecule active

    1 trial
  4. Bictegravir

    Gilead Sciences Ireland UC

    HIV-1-infection

    phase 3 small molecule active

    2 trials
  5. COBI

    Gilead Sciences Ireland UC

    HIV

    phase 3 small molecule completed

    1 trial
  6. E/C/F/TDF

    Gilead Sciences Ireland UC

    Acquired Immunodeficiency Syndrome

    phase 3 small molecule completed

    1 trial
  7. LDV/SOF

    Gilead Sciences Ireland UC

    Hepatitis C Virus

    phase 3 small molecule completed

    1 trial
  8. SOF/VEL

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 3 small molecule completed

    3 trials
  9. SOF/VEL/VOX

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 3 small molecule completed

    1 trial
  10. Sacituzumab Govitecan-hziy

    Gilead Sciences Ireland UC

    Triple Negative Breast Cancer

    phase 3 small molecule active

    1 trial
  11. Sofosbuvir

    Gilead Sciences Ireland UC

    Hepatitis C

    phase 3 small molecule completed

    2 trials
  12. Sofosbuvir

    Gilead Sciences Ireland UC

    Chronic HCV Infection

    phase 3 small molecule completed

    1 trial
  13. Tenofovir DF

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    phase 3 small molecule active

    1 trial
  14. Andecaliximab

    Gilead Sciences Ireland UC

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial
  15. BSF 208075

    Gilead Sciences Ireland UC

    Pulmonary Hypertension

    phase 2 small molecule completed

    1 trial
  16. Presatovir

    Gilead Sciences Ireland UC

    Respiratory Syncytial Virus

    phase 2 small molecule completed

    1 trial
  17. SOF

    Gilead Sciences Ireland UC

    HCV Infection

    phase 2 small molecule completed

    1 trial
  18. SOF

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 2 small molecule completed

    1 trial
  19. VOX

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 2 small molecule completed

    1 trial
  20. B/F/TAF

    Gilead Sciences Ireland UC

    HIV-1-infection

    phase 1 small molecule completed

    1 trial
  21. Evixapodlin

    Gilead Sciences Ireland UC

    Advanced Solid Tumors

    phase 1 small molecule terminated

    1 trial
  22. GS-0272

    Gilead Sciences Ireland UC

    Rheumatoid Arthritis

    phase 1 small molecule active

    1 trial
  23. GS-2829

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    phase 1 mab completed

    1 trial
  24. Lanraplenib.

    Gilead Sciences Ireland UC

    Inflammatory Disease

    phase 1 small molecule completed

    1 trial
  25. SOF/VEL/VOX

    Gilead Sciences Ireland UC

    HCV Infection

    phase 1 small molecule completed

    1 trial
  26. TDF

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    approved small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Gilead Sciences Ireland have?

26 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs